Status:
COMPLETED
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
A new formulation of Fluticasone propionate/Salmeterol comparing a lower dose of fluticasone propionate and salmeterol was compared with concurrent administration of fluticasone propionate and salmete...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Documented history of mild or intermittent asthma
- Have PEF and FEV1\>80% predicted
- Not a smoker
- BMI of 19 - 29
- Exclusion criteria:
- Have had a life threatening episode of asthma
- Have had a respiratory tract infection in the last four weeks
- Have other respiratory disease
- Have taken certain medications within restricted time periods
Exclusion
Key Trial Info
Start Date :
January 28 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2005
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00364442
Start Date
January 28 2005
End Date
April 13 2005
Last Update
September 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Berlin, Germany, 14050